513 related articles for article (PubMed ID: 16227086)
1. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
2. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity.
Fujimoto M; Sato S
J Dermatol Sci; 2007 Apr; 46(1):1-9. PubMed ID: 17223015
[TBL] [Abstract][Full Text] [Related]
3. CD19 regulates B lymphocyte responses to transmembrane signals.
Fujimoto M; Poe JC; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):267-77. PubMed ID: 9695183
[TBL] [Abstract][Full Text] [Related]
4. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
5. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
Sato S; Tuscano JM; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
[TBL] [Abstract][Full Text] [Related]
6. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
Poe JC; Hasegawa M; Tedder TF
Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
[TBL] [Abstract][Full Text] [Related]
7. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
[TBL] [Abstract][Full Text] [Related]
9. CD22 serves as a receptor for soluble IgM.
Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
[TBL] [Abstract][Full Text] [Related]
10. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
11. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
12. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
[TBL] [Abstract][Full Text] [Related]
13. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
[TBL] [Abstract][Full Text] [Related]
14. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
Toda M; Akita K; Inoue M; Taketani S; Nakada H
Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
[TBL] [Abstract][Full Text] [Related]
15. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
Tedder TF; Tuscano J; Sato S; Kehrl JH
Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
[TBL] [Abstract][Full Text] [Related]
16. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.
Nitschke L; Lajaunias F; Moll T; Ho L; Martinez-Soria E; Kikuchi S; Santiago-Raber ML; Dix C; Parkhouse RM; Izui S
Int Immunol; 2006 Jan; 18(1):59-68. PubMed ID: 16291654
[TBL] [Abstract][Full Text] [Related]
17. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
Wakabayashi C; Adachi T; Wienands J; Tsubata T
Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
[TBL] [Abstract][Full Text] [Related]
18. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
Toda M; Hisano R; Yurugi H; Akita K; Maruyama K; Inoue M; Adachi T; Tsubata T; Nakada H
Biochem J; 2009 Feb; 417(3):673-83. PubMed ID: 18925876
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
20. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]